Skip to main content
Category

News Archive

qualcomm-lifes-connect2014-video-medcity

A report card for the digital health ecosystem: Thoughts from Qualcomm Life’s Connect2014

By News Archive

qualcomm-lifes-connect2014-video-medcity

Digital health has a pretty erratic grade point average, or so says Dana Mead, a parter at venture firm Kleiner Perkins, Caufield & Byers. He outlined and graded what he called the five most important elements of the digital health ecosystem at Qualcomm Life‘s Connect2014 conference this week in San Diego, and this is how he slices it:

1. Access to Capital – A

Looking at data over the last quarter, Mead said that about $700 million in funding has been raised in digital health. That’s more than medical device startups raise, about two-thirds of what pharma and biotech raise and about a third of what software/IT companies raised in the same time period. So, not a bad showing for digital health, Mead said.

Read More
sigma-tau-logo

Sigma-Tau, Crosscare ink deal for marketing, distribution of Colief in US – Pharmaceutical Business Review

By News Archive

sigma-tau-logo

Sigma-Tau Pharmaceuticals (Sigma-Tau) has signed an exclusive US license agreement with Ireland-based Crosscare, to market and distribute Colief Infant Drops for the treatment of colic.

As part of the deal, Sigma-Tau will be responsible for the sales, marketing and distribution of Colief in the US.

Sigma-Tau has planned a re-launch of Colief at healthcare professionals as well as consumers in August 2014.

Read More

Top 25 Biotech Companies of 2014 – GEN

By News Archive

gen-top25-biotech-logo

The rich are getting richer when it comes to publicly traded biotechnology companies, judging by their ballooning market capitalization. It’s a product of the current Wall Street surge—some call it a bubble—that continued in the first half of 2013, with 52 companies going public and the overall market closing at record highs.

Following is a list of 25 biotechnology companies, ranked by their market cap as of July 24 as furnished by the exchanges on which they trade their shares, or by other publicly available sources, such as any of several free stock information websites. Figures of non-U.S. companies were converted to U.S. dollars from various currencies.

Read More
nhlbi-southeast-conference

NHLBI Regional Innovation Conference – Southeast

By News Archive

nhlbi-southeast-conference

Monday, September 22, 2014

NHLBI’s Office of Translational Alliances and Coordination (OTAC) hosts this semi-annual Regional Innovation Conference to connect small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech, medical device, and pharmaceutical industries. Attendees will see featured presentations from NHLBI-funded companies, and learn from staff about recent changes in the Federal SBIR/STTR program, and other funding opportunities and cost-free resources available to small businesses.

Previous conferences have been held in Boston, MA, San Francisco, CA, San Diego, CA, and Rockville, MD.

Highlights/ Features:

  • Company presentations 
    • Hear about innovative technologies for heart, lung, blood and sleep disorder and disease indications from companies who have received (non-dilutive) SBIR/STTR funding 
  • How to market your innovation 
    • Our expert panel of investors, legal advisors, and successful entrepreneurs will talk about the highs and lows of early-stage life science investment 
  • Networking 
    • Ample opportunities to network with potential partners,  investors, and NHLBI staff
Read More
johns-hopkins-new-logo

Johns Hopkins accelerator FastForward hits capacity, expands to East Baltimore – Baltimore Business Journal

By News Archive

johns-hopkins-new-logo

Johns Hopkins University’s FastForward business accelerator is so popular the school is expanding it to a second location.

FastForward, which is part of Hopkins’ Whiting School of Engineering, launched last year and is already at capacity with a total of 33 startups and projects. Administrators plan to expand the program in January to accommodate the high demand among students and faculty.

Read More
bio-maryland-logo

BioMaryland, DHMH and CMTP Partner offer $1M to Advance Projects which Improve Patient Outcomes and Reduce Costs

By News Archive

bio-maryland-logo

The BioMaryland Center is partnering with Maryland’s Department of Health and Mental Hygiene (DHMH) and the Center for Medical Technology Policy (CMTP) to incorporate improved health care quality and cost reduction criteria in the selection process for the BioMaryland Center’s annual Biotechnology Awards program. $1M will be awarded to projects, $50,000-200,000 each, advancing technologies toward commercialization–with preference given to projects which improve patient outcomes and reduce costs.

October 1st is the deadline to apply for the next round of Biotechnology Development Awards. More information regarding the program is available online.

How to Apply: Two application forms (the Non-confidential Applicant and Project Summary form and the Confidential Application Details form) and a business plan must be submitted electronically by 5 p.m. EST on October 1, 2014.

Read More
brainscope-logo

Governor O’Malley Announces KoolSpan, BrainScope Tapped for Follow-on Investments from InvestMaryland

By News Archive

brainscope-logo

The Maryland Venture Fund (MVF), the equity investment arm of the Maryland Department of Business and Economic Development (DBED), has made follow-on investments totaling $700,000 in two of its portfolio companies. KoolSpan, developer of a suite of patented, hardware-based mobile security encryption solutions, received $400,000. BrainScope, which is pioneering sophisticated neurotechnology to quickly assess traumatic brain injury at the initial point of care, received $300,000. Both companies are located in Bethesda. The investments were made with funds raised by InvestMaryland, Governor Martin O’Malley’s key initiative designed to spur growth and development of small, high-tech companies in Maryland.

“KoolSpan and BrainScope have both made tremendous progress since the Maryland Venture Fund first invested in them, and we are excited to make these follow-on investments,” said Governor O’Malley. “In Maryland we are committed to supporting the growth of future leaders in industries that keep us safer, healthier and better connected than ever before. KoolSpan and BrainScope are perfect examples of the innovative, high-tech companies that set Maryland’s economy apart and provide the family-sustaining jobs of today and tomorrow.”

Read More
mdbio-foundation-logo-2

MdBioLab Open House (with ice cream!)

By News Archive

mdbio-foundation-logo-2

August 20th, 3-5 PM

MdBio Foundation welcomes you to an open house on the mobile laboratory MdBioLab. Tour the lab, meet the team, or just eat your ice cream – doors open 3 – 5 PM.

KICK OFF THE SCHOOL YEAR WITH AN ICE CREAM CONE AND TOUR OF MDBIOLAB.

MdBioLab will be parked at Howard Community College, 10901 Little Patuxent Pkwy, Columbia, MD 21044, Lot F – adjacent to Little Patuxent Parkway

Read More
Strand-Life-Sciences-logo

Strand Life Sciences: Bringing Genetic Tests To The Average Customer – Forbes India Magazine

By News Archive

strand-life-sciences-logo

When four professors of the Indian Institute of Science (IISc), Bangalore, decided to start Strand Life Sciences in 2000 to aid clinical research through genomic testing using DNA sequencing, the initiative hardly attracted attention. UTI Ventures pumped in $1.3 million a year later and, in 2002, WestBridge Capital Partners invested $1.9 million, but that did not create ripples either. However, things changed dramatically in 2013, when Strand got $10 million from San Francisco-based financial firm Burrill & Co.

It used the capital to roll out personalised genetic test services in collaboration with hospital chains and clinics across India, including Max Hospitals, Mazumdar-Shaw Cancer Center, St. John’s Medical College Hospital, Kidwai Memorial Institute of Oncology and HealthCare Global Enterprises.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.